Squarepoint
ATEX icon

Squarepoint’s Anterix ATEX Stock Holding History

Squarepoint’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,500
Closed -$383K – 4553
2024
Q4 		$383K Buy
+12,500
New +$416K ﹤0.01% 3962

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PM
Plustick Management Charlottesville, Virginia $269M AUM 340.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Squarepoint's ATEX Position: Q2 2026 in Review

Squarepoint sold out of Anterix (ATEX) in Q2 2026, closing a stake of 59,736 shares — an estimated $2.28M sold.

Squarepoint first reported a position in ATEX in Q1 2019 and held it in 19 quarters. The position peaked at $2.28M in Q1 2026. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Squarepoint reported no remaining Anterix position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 59,736 Anterix shares in Q2 2026, an estimated $2.28M.
  • Squarepoint first reported a position in Anterix in Q1 2019 and held it in 19 quarters.
  • Squarepoint's Anterix position peaked at $2.28M in Q1 2026.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.